Ascend Capital’s CR Bard Inc. BCR Stock Holding History

Ascend Capital’s Portfolio BCR Stock Details BCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-33,572	Closed	-$7.54M	–	200
2016 Q4	$7.54M	Buy	+33,572	New	+$7.29M	0.38%	81

Other funds holding BCR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AIM

abrdn Investment Management Edinburgh, United Kingdom $29.6B AUM 25.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Ascend Capital's BCR Position: Q1 2017 in Review

Ascend Capital sold out of CR Bard Inc. (BCR) in Q1 2017, closing a stake of 33,572 shares — an estimated $7.54M sold.

Ascend Capital first reported a position in BCR in Q4 2016 and held it in 1 quarter. The position peaked at $7.54M in Q4 2016. 684 funds tracked by Wall St. Rank hold BCR as of Q1 2017.

Ascend Capital reported no remaining CR Bard Inc. position as of Q1 2017 after selling out during the quarter.
Ascend Capital sold 33,572 CR Bard Inc. shares in Q1 2017, an estimated $7.54M.
Ascend Capital first reported a position in CR Bard Inc. in Q4 2016 and held it in 1 quarter.
Ascend Capital's CR Bard Inc. position peaked at $7.54M in Q4 2016.
684 funds tracked by Wall St. Rank held CR Bard Inc. as of Q1 2017.

Based on Ascend Capital's 13F filing for Q1 2017, filed 15 May 2017.